PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36

ABSTRACT Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal‐dominant degenerative diseases. In particular, SCA36 is characterized by a late‐onset, slowly progressive cerebellar syndrome typically associated with sensorineur...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 32; no. 2; pp. 264 - 273
Main Authors Aguiar, Pablo, Pardo, Julio, Arias, Manuel, Quintáns, Beatriz, Fernández‐Prieto, Montse, Martínez‐Regueiro, Rocío, Pumar, José‐Manuel, Silva‐Rodríguez, Jesús, Ruibal, Álvaro, Sobrido, María‐Jesús, Cortés, Julia
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2017
Subjects
Online AccessGet full text
ISSN0885-3185
1531-8257
DOI10.1002/mds.26854

Cover

Abstract ABSTRACT Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal‐dominant degenerative diseases. In particular, SCA36 is characterized by a late‐onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG‐PET) and MRI scans. Methods Twenty SCA36 patients underwent a study consisting of FDG‐PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG‐PET was carried out using a voxel‐by‐voxel and region‐of‐interest analysis. MRI evaluation was based on visual inspection and volumetric analysis. Results SARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG‐PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years. Conclusions We present the first FDG‐PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. © 2016 International Parkinson and Movement Disorder Society.
AbstractList ABSTRACT Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal‐dominant degenerative diseases. In particular, SCA36 is characterized by a late‐onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG‐PET) and MRI scans. Methods Twenty SCA36 patients underwent a study consisting of FDG‐PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG‐PET was carried out using a voxel‐by‐voxel and region‐of‐interest analysis. MRI evaluation was based on visual inspection and volumetric analysis. Results SARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG‐PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years. Conclusions We present the first FDG‐PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. © 2016 International Parkinson and Movement Disorder Society.
Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases. In particular, SCA36 is characterized by a late-onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG-PET) and MRI scans. Methods Twenty SCA36 patients underwent a study consisting of FDG-PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG-PET was carried out using a voxel-by-voxel and region-of-interest analysis. MRI evaluation was based on visual inspection and volumetric analysis. Results SARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG-PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years. Conclusions We present the first FDG-PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. © 2016 International Parkinson and Movement Disorder Society.
The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases. In particular, SCA36 is characterized by a late-onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG-PET) and MRI scans. Twenty SCA36 patients underwent a study consisting of FDG-PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG-PET was carried out using a voxel-by-voxel and region-of-interest analysis. MRI evaluation was based on visual inspection and volumetric analysis. SARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG-PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years. We present the first FDG-PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. © 2016 International Parkinson and Movement Disorder Society.
BACKGROUNDThe spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases. In particular, SCA36 is characterized by a late-onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG-PET) and MRI scans.METHODSTwenty SCA36 patients underwent a study consisting of FDG-PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG-PET was carried out using a voxel-by-voxel and region-of-interest analysis. MRI evaluation was based on visual inspection and volumetric analysis.RESULTSSARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG-PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years.CONCLUSIONSWe present the first FDG-PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. © 2016 International Parkinson and Movement Disorder Society.
Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases. In particular, SCA36 is characterized by a late-onset, slowly progressive cerebellar syndrome typically associated with sensorineural hearing loss. This study was aimed at analyzing the neurodegenerative process underlying SCA36 through fluorodeoxyglucose positron emission tomography (FDG-PET) and MRI scans. Methods Twenty SCA36 patients underwent a study consisting of FDG-PET and MRI scans. Clinical motor evaluation was performed through the Scale for the Assessment and Rating of Ataxia (SARA). FDG-PET was carried out using a voxel-by-voxel and region-of-interest analysis. MRI evaluation was based on visual inspection and volumetric analysis. Results SARA ranged from 0 to 24.5 (4 patients asymptomatic, 3 with unspecific symptoms, and 13 with cerebellar signs). FDG-PET revealed hypometabolism in the asymptomatic stage in the vermis and right cerebellar hemisphere. In the ataxic stage, hypometabolism spread to both cerebellar hemispheres and the brain stem. MRI was normal in asymptomatic and preataxic individuals and showed superior cerebellar vermis atrophy early in the ataxic stage, diffuse cerebellar atrophy some years into the disease course, and a pattern of olivopontocerebellar atrophy in the oldest patients. There was no significant cerebellar atrophy in patients younger than 50 years. Conclusions We present the first FDG-PET study of SCA36 and one of the largest neuroimaging study of SCAs. Our results revealed neuronal dysfunctions in the vermis and right cerebellar hemisphere as soon as a decade before the onset of motor symptoms. In the ataxic stage, dysfunctions spread to both hemispheres and the brain stem. copyright 2016 International Parkinson and Movement Disorder Society.
Author Pardo, Julio
Sobrido, María‐Jesús
Fernández‐Prieto, Montse
Arias, Manuel
Silva‐Rodríguez, Jesús
Cortés, Julia
Aguiar, Pablo
Quintáns, Beatriz
Ruibal, Álvaro
Martínez‐Regueiro, Rocío
Pumar, José‐Manuel
Author_xml – sequence: 1
  givenname: Pablo
  surname: Aguiar
  fullname: Aguiar, Pablo
  organization: Universidade de Santiago de Compostela (USC)
– sequence: 2
  givenname: Julio
  surname: Pardo
  fullname: Pardo, Julio
  organization: Instituto de Investigaciones Sanitarias de Santiago (IDIS)
– sequence: 3
  givenname: Manuel
  surname: Arias
  fullname: Arias, Manuel
  organization: Instituto de Investigaciones Sanitarias de Santiago (IDIS)
– sequence: 4
  givenname: Beatriz
  surname: Quintáns
  fullname: Quintáns, Beatriz
  organization: Institute of Health Carlos III
– sequence: 5
  givenname: Montse
  surname: Fernández‐Prieto
  fullname: Fernández‐Prieto, Montse
  organization: Institute of Health Carlos III
– sequence: 6
  givenname: Rocío
  surname: Martínez‐Regueiro
  fullname: Martínez‐Regueiro, Rocío
  organization: Universidade de Santiago de Compostela (USC)
– sequence: 7
  givenname: José‐Manuel
  surname: Pumar
  fullname: Pumar, José‐Manuel
  organization: University Hospital of Santiago de Compostela (CHUS)
– sequence: 8
  givenname: Jesús
  surname: Silva‐Rodríguez
  fullname: Silva‐Rodríguez, Jesús
  organization: University Hospital of Santiago de Compostela (CHUS), IDIS Health Research Institute
– sequence: 9
  givenname: Álvaro
  surname: Ruibal
  fullname: Ruibal, Álvaro
  organization: Universidade de Santiago de Compostela (USC)
– sequence: 10
  givenname: María‐Jesús
  surname: Sobrido
  fullname: Sobrido, María‐Jesús
  email: Maria.Jesus.Sobrido.Gomez@sergas.es
  organization: Institute of Health Carlos III
– sequence: 11
  givenname: Julia
  surname: Cortés
  fullname: Cortés, Julia
  organization: Universidade de Santiago de Compostela (USC)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27862279$$D View this record in MEDLINE/PubMed
BookMark eNqN0TtPwzAQB3ALgWgLDHwBZImFJcWPOHZGVApUogLxmCMnvlSpEifYCdBvjymPgYnpLN1Ppzv_J2jXthYQOqZkSglh543xU5YoEe-gMRWcRooJuYvGRCkRcarECE28XxNCqaDJPhoxqRLGZDpG-f38CWtr8PJhgQ30UPRVa3FbYtCu3mxbnWtXDryvXgFbGFxrYAUWnN7SymLfVbYtwEEOda0d1r1-rzTuNx1gnhyivVLXHo6-6wF6vpo_zW6i27vrxeziNlpzqeKo0CBUrE0sS1YanuRGxTyFWPJSpaLkNBdJYXheUmMgVyaFVBrGQEoSUE75ATr7mhv2fRnA91lT-eJzIwvt4DOqpFSUSfkfGlOZShmTQE__0HU7OBsOCSpJUybCxKBOvtWQN2CyzlWNdpvs56MDOP8Cb1UNm98-JdlngllIMNsmmC0vH7cP_gEchY7C
CODEN MOVDEA
ContentType Journal Article
Copyright 2016 International Parkinson and Movement Disorder Society
2016 International Parkinson and Movement Disorder Society.
2017 International Parkinson and Movement Disorder Society
Copyright_xml – notice: 2016 International Parkinson and Movement Disorder Society
– notice: 2016 International Parkinson and Movement Disorder Society.
– notice: 2017 International Parkinson and Movement Disorder Society
DBID CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
DOI 10.1002/mds.26854
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
Nursing & Allied Health Premium
MEDLINE
MEDLINE - Academic
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 273
ExternalDocumentID 4315418341
27862279
MDS26854
Genre article
Journal Article
GrantInformation_xml – fundername: Instituto de Salud Carlos III
  funderid: PI12/00742; PI12/01013
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
XG1
XV2
ZGI
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CGR
CUY
CVF
ECM
EIF
NPM
YCJ
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
ID FETCH-LOGICAL-j3784-cae584ad47f2fd36bd8439e473f895f31b56cd3bf1ddeb8d9e97d22e770e47b13
IEDL.DBID DR2
ISSN 0885-3185
IngestDate Fri Jul 11 05:33:48 EDT 2025
Fri Jul 11 16:36:37 EDT 2025
Sun Jul 13 04:37:43 EDT 2025
Thu Apr 03 07:04:39 EDT 2025
Sun Sep 21 06:19:58 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords neurodegeneration
preataxic stage
ataxia
MRI
PET
Language English
License 2016 International Parkinson and Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-j3784-cae584ad47f2fd36bd8439e473f895f31b56cd3bf1ddeb8d9e97d22e770e47b13
Notes P. Aguiar is awarded a public fellowship from
POS‐A/2013/001. R. Martínez‐Regueiro is supported by a public fellowship from ISCIII/FI14/00510/cofunded by FEDER. No other potential conflict of interest relevant to this article was reported.
Pablo Aguiar and Julio Pardo contributed equally to this work.
Plan I2C ‐ Xunta de Galicia
Relevant conflicts of interest/financial disclosures
Funding agencies
This work was supported by public projects PI12/01013, integrated in the Plan Estatal de I+D+I 2013‐2016, and PI12/00742 (Institute of Health Carlos III and ISCIII‐Subdirección General de Evaluación y Fomento de la Investigación del Fondo Europeo de Desarrollo Regional [FEDER] funds).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 27862279
PQID 1869925277
PQPubID 1016421
PageCount 10
ParticipantIDs proquest_miscellaneous_1877812771
proquest_miscellaneous_1841797740
proquest_journals_1869925277
pubmed_primary_27862279
wiley_primary_10_1002_mds_26854_MDS26854
PublicationCentury 2000
PublicationDate February 2017
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: February 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2011; 258
2002; 15
2004; 61
2004; 3
2008; 7
2012; 19
2002; 319
2010; 81
2012; 79
1998; 64
2012; 53
2004; 55
2009; 36
2016; 2
2012; 135
2004; 19
2006; 21
2013; 12
2006; 66
2015; 86
2015; 85
2007; 254
2013; 31
2013; 136
2008; 23
2011; 89
2015
1999; 112
2005; 12
1994; 4
References_xml – volume: 64
  start-page: 499
  issue: 4
  year: 1998
  end-page: 504
  article-title: Positron emission tomography in asymptomatic gene carriers of Machado‐Joseph disease
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 23
  start-page: 1154
  issue: 8
  year: 2008
  end-page: 1160
  article-title: PET study of brain acetylcholinesterase in cerebellar degenerative disorders
  publication-title: Mov Disord
– volume: 66
  start-page: 1717
  year: 2006
  end-page: 1720
  article-title: Scale for the assessment and rating of ataxia: development of a new clinical scale
  publication-title: Neurology
– volume: 86
  start-page: 986
  year: 2015
  end-page: 995
  article-title: Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 81
  start-page: 529
  issue: 5
  year: 2010
  end-page: 532
  article-title: The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 89
  start-page: 121
  year: 2011
  end-page: 130
  article-title: Expansion of Intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement
  publication-title: Am J Hum Genet
– volume: 12
  start-page: 725
  issue: 9
  year: 2005
  end-page: 728
  article-title: PET and MRI in SCA2: a study of symptomatic and asymptomatic individuals
  publication-title: Eur J Neurol
– volume: 19
  start-page: 1070
  year: 2012
  end-page: 1078
  article-title: Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan
  publication-title: Eur J Neurol
– volume: 85
  start-page: 96
  year: 2015
  end-page: 103
  article-title: The preclinical stage of spinocerebellar ataxias
  publication-title: Neurology
– volume: 135
  start-page: 1423
  year: 2012
  end-page: 1435
  article-title: Costa da Morte’ ataxia is spinocerebellar ataxia 36: Clinical and genetic characterization
  publication-title: Brain
– volume: 136
  start-page: 905
  year: 2013
  end-page: 917
  article-title: Genotype‐specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6
  publication-title: Brain
– volume: 319
  start-page: 91
  issue: 2
  year: 2002
  end-page: 94
  article-title: Lateralized organization of the cerebellum in a silent verbal fluency task: a functional magnetic resonance imaging study in healthy volunteers
  publication-title: Neurosci Lett
– volume: 12
  start-page: 650
  issue: 7
  year: 2013
  end-page: 658
  article-title: Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
  publication-title: Lancet Neurol
– volume: 21
  start-page: 872
  issue: 6
  year: 2006
  end-page: 875
  article-title: Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17
  publication-title: Mov Disord
– volume: 61
  start-page: 933
  issue: 6
  year: 2004
  end-page: 937
  article-title: Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6
  publication-title: Arch Neurol
– volume: 2
  start-page: e68
  issue: 3
  year: 2016
  article-title: Spinocerebellar ataxia type 36 in the Han Chinese
  publication-title: Neurol Genet
– volume: 15
  start-page: 273
  year: 2002
  end-page: 289
  article-title: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single‐subject brain
  publication-title: Neuroimage
– volume: 79
  start-page: 333
  year: 2012
  end-page: 341
  article-title: Clinical features of SCA36. A novel spinocerebellar ataxia with motor neuron involvement (Asidan)
  publication-title: Neurology
– volume: 112
  start-page: 767
  issue: 120
  year: 1999
  end-page: 774
  article-title: [Revalidation and standardization of the cognition mini‐exam (first Spanish version of the Mini‐Mental Status Examination) in the general geriatric population]
  publication-title: Med Clin (Barc)
– start-page: 363
  year: 2015
  end-page: 384
– volume: 19
  start-page: 1320
  issue: 11
  year: 2004
  end-page: 1325
  article-title: Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I‐betaCIT and 123I‐IBZM SPECT study
  publication-title: Mov Disord
– volume: 254
  start-page: 838
  issue: 7
  year: 2007
  end-page: 845
  article-title: Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: a voxel‐based FDG‐positron emission tomography analysis
  publication-title: J Neurol
– volume: 258
  start-page: 308
  issue: 2
  year: 2011
  end-page: 310
  article-title: Striatal dopamine function in a family with multiple SCA‐3 phenotypes
  publication-title: J Neurol
– volume: 53
  start-page: 1074
  issue: 7
  year: 2012
  end-page: 1080
  article-title: PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17
  publication-title: J Nucl Med
– volume: 55
  start-page: 426
  issue: 3
  year: 2004
  end-page: 430
  article-title: Reduced striatal [123 I]FP‐CIT binding in SCA2 patients without parkinsonism
  publication-title: Ann Neurol
– volume: 7
  start-page: 304
  year: 2008
  end-page: 313
  article-title: Functional asymmetry in the cerebellum: a brief review
  publication-title: Cerebellum
– volume: 36
  start-page: 2103
  issue: 12
  year: 2009
  end-page: 2110
  article-title: EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 4
  start-page: 8
  year: 1994
  end-page: 26
  article-title: Practice‐related changes in human brain functional anatomy during non motor learning
  publication-title: Cereb Cortex
– volume: 3
  start-page: 291
  year: 2004
  end-page: 304
  article-title: Autosomal dominant cerebellar ataxias: clinical features, genetics and pathogenesis
  publication-title: Lancet Neurol
– volume: 31
  start-page: 987
  issue: 4
  year: 2013
  end-page: 1007
  article-title: Clinical neurogenetics: autosomal dominant spinocerebellar ataxia
  publication-title: Neurol Clin
SSID ssj0011516
Score 2.2894006
Snippet ABSTRACT Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal‐dominant degenerative...
The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases. In...
Background The spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases....
BACKGROUNDThe spinocerebellar ataxias (SCAs) form a clinically, genetically, and pathological heterogeneous group of autosomal-dominant degenerative diseases....
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 264
SubjectTerms Adult
Aged
ataxia
Brain Stem - diagnostic imaging
Brain Stem - metabolism
Brain Stem - pathology
Cerebellar Vermis - diagnostic imaging
Cerebellar Vermis - metabolism
Cerebellar Vermis - pathology
Cerebellum - diagnostic imaging
Cerebellum - metabolism
Cerebellum - pathology
Disease Progression
Female
Humans
Magnetic Resonance Imaging - methods
Male
Middle Aged
Movement disorders
MRI
neurodegeneration
Nuclear Proteins
PET
Positron-Emission Tomography - methods
preataxic stage
Severity of Illness Index
Spinocerebellar Ataxias - diagnosis
Spinocerebellar Ataxias - diagnostic imaging
Spinocerebellar Ataxias - metabolism
Spinocerebellar Ataxias - pathology
Title PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.26854
https://www.ncbi.nlm.nih.gov/pubmed/27862279
https://www.proquest.com/docview/1869925277
https://www.proquest.com/docview/1841797740
https://www.proquest.com/docview/1877812771
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CDiGXNm3SdvNCgR568WYt2RqLnkIeJIENJQ_IoWAkSwqbEG_Y9YbQX9-RvOvQUkrpzTAjsBnNzGdp5huAz0J4pwpyQGU8JhnliEQXJk2Ut5oEPLVZaE4eXsjTm-z8Nr9dgq-LXpiWH6I7cAueEeN1cHBtpvuvpKGPdtrnssgDF2gqZODNP7rsqKMI6MSxp-REeewQXrAKDfh-t_JPqPJXkBqzzMlb-L54v7a45KE_a0y_-vEbdeN_fsAavJmjT3bQbpd3sOTq97AynN-vr4P5dnzNdG3Z8PKMWdfEOq2ajT1zgQg5imJFVyiefXYssmFadxe5q6PqqGbTp1FNWXHiwp2GnjDd6JeRZuGwlwm5ATcnx9eHp8l8CkNyL7DIkko7AinaZui5t0IaWxCIcRkKX6jci9TksrLC-JQipSmscgot5w5xQEomFR9guR7X7hMwIxW6SlotZZFZTI2giMErZSrucisGPdhe2KOcu9K0DDOzFKkh9mCvE5MThJsNXbvxLOiEQWqEZAd_00EkNIOY9uBja-vyqWX0KDnSjx1H1YMv0WKdoCV15iXZqoy2KodHV_Fh899Vt2CVBzAQa723YbmZzNwOQZnG7MY9-xNgg-_D
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3faxQxEB5qBe1L66_as1Uj-ODLXm-T3cwGfBFtuWq3SL1CX2RJNolcxb1ytyfiX-8ke7eiiIhvCzOBXSaT-XZm8g3AcyG8UwU5oDIek4xiRKILkybKW00CntosXE4uz-T4Int7mV9uwMv1XZiOH6JPuAXPiOd1cPCQkD78yRr6xS6GXBZ5dgNuxvpcgETnPXkUQZ04-JTcKI93hNe8QiN-2C_9E678FabGOHO8Ax_Xb9i1l3weLlszrL__Rt74v59wB7ZXAJS96nbMXdhwzT24Va5K7PfBvD-aMN1YVp6fMOva2KrVsJlnLnAhR1Fs6gr9s18di4SY1n2K9NVRddqwxfW0ocA4d6GsoedMt_rbVLOQ72VCPoCL46PJ63GyGsSQXAkssqTWjnCKthl67q2QxhaEY1yGwhcq9yI1uaytMD6lw9IUVjmFlnOHOCIlk4pd2GxmjdsDZqRCV0urpSwyi6kRdGjwWpmau9yK0QAO1gapVt60qMLYLEVqiAN41ovJD0JxQzdutgw6YZYagdnR33QQCdAgpgN42Bm7uu5IPSqO9G_HUQ3gRTRZL-h4nXlFtqqiraryzYf48OjfVZ_C7fGkPK1OT87e7cMWD9ggtn4fwGY7X7rHhGxa8yRu4B9hhfPh
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3faxQxEB5qheJL_a2nVSP44Mteb5NsZoNPYnu06pVSW-iDsCSbRM7i3nG3J-Jf7yR7t6KIiG8LM4FdJjPzbTLzDcALIYLXJTmgtgEzSTkiM6XNMx2cIQHPnYzNyZMTdXQh314Wl1vwatML0_FD9Adu0TNSvI4OPndh_ydp6Be3HHJVFvIaXJeK0mRERGc9dxQhnTT3lLyoSC3CG1qhEd_vl_4JVv6KUlOaGd-Ej5sX7KpLroar1g7r779xN_7nF9yC3TX8ZK-7_XIbtnxzB3Ym6wv2u2BPD8-ZaRybnB0z59tUqNWwWWA-MiEnUSrpitWzXz1LdJjOf0rk1Ul12rDlfNpQWlz4eKlhFsy05tvUsHjay4S6Bxfjw_M3R9l6DEP2WWAps9p4QinGSQw8OKGsKwnFeIkilLoIIreFqp2wIadQaUunvUbHuUcckZLNxX3YbmaNfwjMKo2-Vs4oVUqHuRUUMnitbc194cRoAHsbe1RrX1pWcWiWJjXEATzvxeQF8WrDNH62ijpxkhpB2dHfdBAJziDmA3jQ2bqad5QeFUf6s-OoB_AyWawXdKzOvCJbVclW1eTgQ3p49O-qz2Dn9GBcvT8-efcYbvAIDFLd9x5st4uVf0KwprVP0_b9AZXh8pA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET+and+MRI+detection+of+early+and+progressive+neurodegeneration+in+spinocerebellar+ataxia+type+36&rft.jtitle=Movement+disorders&rft.au=Aguiar%2C+Pablo&rft.au=Pardo%2C+Julio&rft.au=Arias%2C+Manuel&rft.au=Quint%C3%A1ns%2C+Beatriz&rft.date=2017-02-01&rft.eissn=1531-8257&rft.volume=32&rft.issue=2&rft.spage=264&rft.epage=273&rft_id=info:doi/10.1002%2Fmds.26854&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon